The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 5, 2009, Pages 305-310

  Olszowska, Anna ^a   Zelichowski, Grzegorz ^a   Waniewski, Jacek ^b   Stachowska Piȩtka, Joanna ^b   Weryński, Andrzej ^b   Wańkowicz, Zofia ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

Author keywords

Icodextrin; Peritoneal dialysis; Peritoneal transport

Indexed keywords

DIALYSIS FLUID; HUMAN ALBUMIN; ICODEXTRIN; IODINE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSATE; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; MALE; MEMBRANE TRANSPORT; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL FLUID LEVEL; PERITONITIS; THERMODYNAMICS; ULTRAFILTRATION; WATER TRANSPORT;

EID: 67649337113     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.680     Document Type: Article

References (29)

1. Wańkowicz Z. [Peritoneal dialysis - 40 years of personal experience]. Pol Arch Med Wewn. 2004; 112:19.
2. Gokal R. Fluid management and cardiovascular outcome in peritoneal dialysis patients. Semin Dial. 1999; 12: 26.
3. Enia G, Maltamaci R Benedetto FA, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patient. Nephrol Dial Transplant. 2001; 7:1459.
4. Nakayama M, Kawaguchi Y. Water and electrolyte balance (WEB) Study Group in CAPD. Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients. Perit Dial Int. 2002; 3: 411.
5. Srlaruks S, Sirivongs D, Chunlertrith D. Left ventricular hypertrophy and clinical outcome in CAPD patients. Perit Dial Int. 2000; 20: 461.
6. Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol. 2002; 13: 2787.
7. Wańkowicz Z. [Physiological and clinical importance of increased peritoneum permeability). In: Wiȩcek A, Kokót F, eds. [Progress in nephrology and hypertension], Krakow, Medycyna Praktyczna, 2003: 201.
8. Heimbürger 0, Waniewski J, Weryhski A, et al. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int. 1992; 5:1320.
9. Davies SJ, Brown B, Bryan J, et al. Clinical evaluation of ihe peritoneal equilibration test: a population-based study. Nephrol Dial Transplant. 1993; 1:64.
10. Brown EA, Davies SJ, Rutherford P, et al. Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study. J Am Soc Nephrol. 2003; 14: 2948.
11. Davies SJ, Phillips L, Griffiths A. et al. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998; 54: 2207.
12. Wilkie ME, Plant MJ, Edwards L, et al. Icodextrin 7.5% dialysate solution (glucose polymer] in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int. 1997; 17: 84.
13. Davies S, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003; 14: 2338.
14. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int. 1994:14 (Suppl 3): S158.
15. Bertoli SV, Ciurlino D, Maccario M, et al. Home peritoneal ultrafiltra tion in patient with severe congestive heart failure without end-stage renal disease. Adv Perit Dia. 2005; 21:123.
16. Basile C, Chimienti D, Bruna A, et al. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int. 2009; 29:116.
17. Babb AL, Johansen PJ, Strand MJ, et al. Bi-directional permeability of the human peritoneum to middle molecules. Proc Eur Dial Transplant Ass. 1973:10:247.
18. Randerson DH, Farrell PC. Mass transport properties of the human peritoneum. ASAI0 J. 1980; 3: 140.
19. Waniewski J, Weryński A, Heimbürger O, Lindholm B. A comparative analysis of mass transfer models in peritoneal dialysis. ASAI0 Trans. 1991;37:65.
20. Mistry CD, Gokal R, Peers E. and the MIDAS Study Group. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solution in CAPD. Kidney Int. 1994; 46: 496.
21. Woodrow G, Stables G, Oldroyd B, et al. Comparison of ikodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant. 1999; 14:1530.
22. Posthuma N, Wee PM, Donker AJ, et al. Assessment of the effectiveness, safety and biocompatibility of icodextrin in automated peritoneal dialysis. Perit Dial Int. 2000; 20 (Suppl 2): S106.
23. Neri L, Viglino G, Cappelletti A, et al. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Adv Perit Dial. 2000; 16:174.
24. Jeloka TK, Ersoy FF, Yavuz M, et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int. 2006; 26: 336.
25. Ho-Dac Pannekeet MM, Schouten N, Langen MJ, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int. 1996; 50: 979.
26. Krediet RT, Struijk DG, Gerardus C, et al. Peritoneal fluid kinetics during CAPD measured with intraperitoneal Dextran 70. ASAI0 Trans. 1991; 37: 662.
27. Dranitzki M. CAPD to improve quality of the life in patients with refractory heart failure. Nephrol Dial Transplant. 1998; 13: 3041.
28. Kagan A, Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant. 2005; 20: 28.
29. Gotloib L, Fudm R, Yakubovich M, et al. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant. 2005; 20 (Suppl 7): 32.